A detailed history of Dundas Partners LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Dundas Partners LLP holds 182,113 shares of ZTS stock, worth $30 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
182,113
Previous 140,982 29.17%
Holding current value
$30 Million
Previous $24.4 Million 45.59%
% of portfolio
2.58%
Previous 1.9%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $7.1 Million - $8.08 Million
41,131 Added 29.17%
182,113 $35.6 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $1.68 Million - $2.07 Million
11,576 Added 8.95%
140,982 $24.4 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $2.52 Million - $2.9 Million
15,067 Added 13.18%
129,406 $22.5 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $2.71 Million - $3.25 Million
18,596 Added 19.42%
114,339 $19 Million
Q4 2022

Feb 08, 2023

BUY
$131.14 - $157.47 $805,593 - $967,338
6,143 Added 6.86%
95,743 $14 Million
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $951,105 - $1.22 Million
6,098 Added 7.3%
89,600 $15.4 Million
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $3.86 Million - $4.98 Million
21,273 Added 34.19%
83,502 $15.7 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $3.69 Million - $4.71 Million
-19,067 Reduced 23.45%
62,229 $12.4 Million
Q4 2019

Feb 07, 2020

BUY
$116.25 - $133.25 $104,625 - $119,925
900 Added 1.12%
81,296 $10.8 Million
Q3 2019

Nov 01, 2019

SELL
$112.57 - $128.43 $4.19 Million - $4.78 Million
-37,233 Reduced 31.65%
80,396 $10 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $1.62 Million - $1.81 Million
-19,362 Reduced 14.13%
117,629 $13.4 Million
Q2 2018

Jul 26, 2018

SELL
$79.9 - $89.2 $2.09 Million - $2.33 Million
-26,156 Reduced 16.03%
136,991 $11.7 Million
Q1 2018

Jun 06, 2018

BUY
$71.51 - $84.69 $11.7 Million - $13.8 Million
163,147 New
163,147 $13 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Dundas Partners LLP Portfolio

Follow Dundas Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dundas Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Dundas Partners LLP with notifications on news.